Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
248
days
Parallel processing of T cells and natural killer cells to enhance in vivo CAR T cell activity against blood and solid cancers
AuthorsLachlan J Dobson; Patrick W Marron; Ariana HT Drabble; Thiloma D Liyanage; Kristine C Pe; Clare Y Slaney; Barry D Hock; Alexander D McLellan
Affiliations1. Department of Microbiology and Immunology The University of Otago Dunedin New Zealand; 2. Charles Perkins Centre, Faculty of Medicine and Health, School of Medical Sciences University of Sydney Camperdown NSW Australia; 3. Cancer Immunology Program Peter MacCallum Cancer Centre Melbourne VIC Australia; 4. Sir Peter MacCallum Department of Oncology University of Melbourne Parkville VIC Australia; 5. Haematology Research Group, Department of Pathology and Biomedical Science University of Otago Christchurch New Zealand; 6. Haematology Department Christchurch Hospital Christchurch New Zealand; 7. Department of Histology, Faculty of Medicine University of Indonesia Jakarta Indonesia
44
days
Peripheral immune dynamics during treatment predict prognosis in HCC receiving TACE plus ICIs and anti‐ VEGF / TKIs
AuthorsLihao Qin; Linzhou Zhu; Hao Yang; Wanci Li; Shuai Zhang; Jian Shen; Xiaoli Zhu
Affiliations1. Department of Interventional Radiology The First Affiliated Hospital of Soochow University Suzhou People's Republic of China; 2. Department of Epidemiology and Biostatistics, School of Public Health Medical College of Soochow University Suzhou People's Republic of China
125
days
Sustained response to rituximab in an ANCA‐negative necrotizing vasculitis with initial detection of Corynebacterium kroppenstedtii
AuthorsNadine Al‐Azem; Anna Knothe; Jan‐Dirk Raguse; Inga Nierkamp; Achim Georg Beule; Claudia Rudack; Friedericke Müller; Anne Kerlikowki; Eva Wardelmann; Hermann Pavenstädt; Martin A Kriegel; Rebecca Hasseli
Affiliations1. Section of Rheumatology and Clinical Immunology, Department of Medicine D University Hospital Münster Münster Germany; 2. Department of Oral and Maxillofacial Surgery Fachklinik Hornheide Münster Germany; 3. Clinic for Ear, Nose, and Throat Disorders University Hospital Münster Münster Germany; 4. Center for Diseases of the Upper Airway University Clinic Münster Münster Germany; 5. Department of Otorhinolaryngology, Head and Neck Surgery University Medicine Greifswald Greifswald Germany; 6. Gerhard‐Domagk‐Institute of Pathology University Hospital Münster Münster Germany; 7. Department of Translational Rheumatology and Immunology, Institute for Musculoskelettal Medicine University of Münster Münster Germany; 8. Institute of Immunology University of Münster Münster Germany
301
days
Humoral and cellular responses to SARS‐CoV‐2 variants after ancestral COVID‐19 vaccines in people with HIV and lung transplant recipients
AuthorsDavid WJ Griffin; Paul A Gill; Irene Boo; Shir Sun; Raffi Gugasyan; Alina Wang; Scott J Bornheimer; Stuart Turville; Anupriya Aggarwal; Greg I Snell; Glen P Westall; Emily SJ Edwards; Anna Coldham; Menno C van Zelm; Heidi E Drummer; James H McMahon
Affiliations1. Department of Infectious Diseases Alfred Health and Monash University Melbourne VIC Australia; 2. Department of Immunology, School of Translational Medicine Monash University Melbourne VIC Australia; 3. Viral Entry and Vaccines Group Burnet Institute Melbourne VIC Australia; 4. Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity University of Melbourne Melbourne VIC Australia; 5. Department of Microbiology Monash University Clayton VIC Australia; 6. Diagnostic Markers in Chronic Immune Disorders Group Burnet Institute Melbourne VIC Australia; 7. Immunohaematology Research Group, Centre for Cancer Research Hudson Institute of Medical Research Clayton VIC Australia; 8. BD Biosciences San Jose CA USA; 9. The Kirby Institute University of New South Wales Sydney NSW Australia; 10. Lung Transplant Service Alfred Health Melbourne VIC Australia; 11. Department of Immunology Erasmus MC, University Medical Center Rotterdam the Netherlands
174
days
CD4 + T‐cell responses directed towards A/H5N1‐derived haemagglutinin peptides increase in patients with seasonal influenza A virus infection
AuthorsLilith F Allen; Louise C Rowntree; Mitchell Jenzen; Ruth R Hagen; Nathan P Croft; Fiona James; Genevieve E Martin; Anthony W Purcell; Patricia T Illing; Steven Y C Tong; Allen C Cheng; Tom C Kotsimbos; Jason A Trubiano; Katherine Kedzierska; Thi H O Nguyen
Affiliations1. Department of Microbiology and Immunology The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia; 2. Department of Biochemistry and Molecular Biology, Immunity Program, Biomedicine Discovery Institute Monash University Clayton VIC Australia; 3. Department of Human‐Centred Computing Monash University Clayton VIC Australia; 4. Department of Infectious Diseases and Immunology Austin Health Heidelberg VIC Australia; 5. Victorian Infectious Diseases Service, The Royal Melbourne Hospital Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia; 6. Department of Infectious Diseases University of Melbourne, at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia; 7. School of Public Health and Preventive Medicine Monash University Melbourne VIC Australia; 8. Monash Infectious Diseases, Monash Health and School of Clinical Sciences Monash University Clayton VIC Australia; 9. Department of Respiratory Medicine The Alfred Hospital Melbourne VIC Australia; 10. Department of Medicine, Central Clinical School, The Alfred Hospital Monash University Melbourne VIC Australia; 11. Department of Infectious Diseases Peter MacCallum Cancer Centre Melbourne VIC Australia; 12. National Centre for Infections in Cancer Peter MacCallum Cancer Centre Melbourne VIC Australia; 13. Center for Influenza Disease and Emergence Response (CIDER) Athens GA USA
146
days
High IL ‐10 levels during CRS are negatively associated with NK ‐cell recovery after CAR ‐T cell therapy
AuthorsXindi Wang; Wenjing Luo; Yingying Li; Jianghua Wu; Lu Tang; Chenggong Li; Qiaolin Liu; Zhihan Chen; Yu Hu; Heng Mei
Affiliations1. Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China; 2. Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease Wuhan China; 3. Key Laboratory of Biological Targeted Therapy (Huazhong University of Science and Technology) Ministry of Education Wuhan China
111
days
Safety and immunogenicity of an adjuvanted human onchocerciasis vaccine candidate, Ov MANE1 : preclinical evaluation in a mice model
AuthorsDerrick Neba Nebangwa; Mary Teke Efeti; Sonia M. E. Momnougui; Cabirou Mounchili Shintouo; Robert Adamu Shey; Rene Bilingwe Ayiseh; Fidele Ntie‐Kang; Stephen Mbigha Ghogomu
Affiliations1. Department of Biochemistry and Molecular Biology, Faculty of Science University of Buea Buea Cameroon; 2. Center for Drug Discovery University of Buea Buea Cameroon; 3. CoVACC, Community‐Led Vaccination Yaoundé Cameroon; 4. Frailty in Ageing Research Group Vrije University Brussels Brussels Belgium; 5. Department of Gerontology, Faculty of Medicine and Pharmacy Vrije University Brussels Brussels Belgium; 6. Graduate School of Life Sciences Julius‐Maximilians University WÜrzburg WÜrzburg Germany; 7. Department of Microbiology and Immunology, College of Medicine Drexel University Philadelphia Pennsylvania USA; 8. Drugs and Molecular Diagnostic Laboratory, Biotechnology Unit University of Buea Buea Cameroon; 9. Department of Chemistry, Faculty of Science University of Buea Buea Cameroon; 10. Institute of Pharmacy Martin‐Luther University of Halle‐Wittenberg Halle Germany
61
days
Early brain‐penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1 ‐related Aicardi‐Goutières syndrome
AuthorsRussell C Dale; Jessica Hayes; Velda X Han; Ruwani Dissanayake; Xianzhong Lau; Michelle Farrar; Brian Gloss; Markus Hofer; Esther Tantsis; Michelle Lorentzos; Safiyyah Abbas; Yanick J Crow; Shekeeb Mohammad; Shrujna Patel
Affiliations1. Kids Neuroscience Centre, Faculty of Medicine and Health, The Children's Hospital at Westmead University of Sydney Sydney NSW Australia; 2. Faculty of Medicine and Health, The Children's Hospital at Westmead Clinical School University of Sydney Sydney NSW Australia; 3. Khoo Teck Puat‐National University Children's Medical Institute National University Health System Singapore Singapore; 4. Australian Genome Research Facility Ltd Westmead NSW Australia; 5. Australian Genome Research Facility Ltd Melbourne VIC Australia; 6. Department of Neurology The Sydney Children's Hospitals Network Sydney NSW Australia; 7. Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health University of New South Wales Sydney NSW Australia; 8. Westmead Research Hub Westmead Institute for Medical Research Westmead NSW Australia; 9. School of Life and Environmental Sciences, Faculty of Science The University of Sydney Sydney NSW Australia; 10. Charles Perkins Centre The University of Sydney Sydney NSW Australia; 11. MRC Human Genetics Unit, Institute of Genetics and Cancer University of Edinburgh Edinburgh UK; 12. Université Paris Cité, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation INSERM UMR 1163 Paris France
209
days
Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis
AuthorsMerve Çebi; Arman Çakar; Hacer Durmuş; Yeşim Parman; Güher Saruhan‐Direskeneli
Affiliations1. Department of Physiology, Istanbul Medical Faculty Istanbul University Istanbul Turkey; 2. Department of Neurology, Istanbul Medical Faculty Istanbul University Istanbul Turkey
108
days
Development and functional adaptation of intestinal macrophages across the lifespan
AuthorsBaha Mustafa; Elisa L Hill‐Yardin; Sarah J Spencer
Affiliations1. School of Health and Biomedical Sciences RMIT University Bundoora Melbourne VIC Australia
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days